The Dentaid Research Centre has been very active from the beginning of the pandemic searching how to help oral health care professionals and patients in the fight against Cov-2. As a result of their research, Dentaid is really proud to share with us the current study, published half July in the Journal of Dental Research, confirming that: “Cetylpyridinium Chloride (CPC), a chemical component present in some mouthwashes, reduces the infection capacity of the Alpha variant of SARS-CoV-2 –that is, the variant first described in the UK– by more than 1,000 times in studies carried out in cells in the laboratory”.

This study was carried out with Dentaid products: Perio·Aid Intensive Care, Vitis Gingival and Vitis CPC Protect.


Read more